Drug prices skyrocket in 2026 as drugmakers plan hikes on 350 medications, despite Trump administration affordability pledges.

Consumers could save up to $5,400 a year by price shopping for their medications, according to a new study published by the U.S. Public Interest Research Group. For its survey, the research group ...

What is known is that PBM companies, in general, have higher profit margins than drug manufacturers. | Opinion ...

A CVS Pharmacy location in California. The Federal Trade Commission says that healthcare conglomerates such as CVS, UnitedHealth and Cigna are finding new ways to raise prices on prescription drugs.

Discouraged by a lack of action from Congress, leaders from America’s largest pharmacy associations marched with dozens of demonstrators Friday outside the St. Louis-based headquarters of Express ...

The major PBMs rely on our mistrust of the prescription drug industry, plus their opaque business models, to maintain sky-high prices and profits ($28 billion in 2019). Rather than growing profit ...

Maryland policymakers have touted the Prescription Drug Affordability Board (PDAB) as their solution to high drug prices. Instead of tackling the root causes, these price-setting boards could ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah College of Pharmacy. Anderson is an assistant professor in the Department ...

One of the nation's largest pharmacy chains is planning to overhaul the way it reimburses its pharmacies for prescriptions as the industry works to provide greater clarity on drug pricing. CVS ...

Prescription drug prices remain high despite the fact that the Biden Administration—and its predecessors—have declared reducing prices as a top priority, and the public has been demanding action on ...